Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Gynecol Oncol. 2018 Oct 16;151(3):433–437. doi: 10.1016/j.ygyno.2018.10.006

Table 4:

Transfusion and Postoperative Outcomes (N= 41)

Allogenic RBC transfusion (total) Number of Patients (%)
  Patients (%) 14 (34%)
  Units 25
Allogenic RBC transfusion (intraoperative)
  Patients (%) 2 (5%)
  Units 6
Median length of stay, days (range) 8 (3 – 29)
30-day complications (%)
  Any grade 29 (71%)
  ≥ grade 3 8 (20%)
  Anastomotic leak 2 of 28 (7%)

RBC, red blood cell

Endpoint below predetermined thresholds for safety and efficacy